An open-label non-comparable multi-center long-term study to assess the safety and efficacy of KRP-114V in Japanese subjects with symptoms of overactive bladder

Long-term study of KRP-114V

Status

Unknown

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080222748

Enrollment

160

Registered

2015-02-09

Start date

2015-02-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive bladder(OAB)

Interventions

investigational material(s) Generic name etc : KRP-114V INN of investigational material : Therapeutic category code : 251 Agents affecting urinary organs Dosage and Administration for Investigational

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient showing clear OAB symptoms

Exclusion criteria

Exclusion criteria: Lower urinary tract symptoms except OAB

Design outcomes

Primary

Measure	Time frame
Safety Adverse event, Laboratory test	—

Secondary

Measure	Time frame
Efficacy (average number of micturition number, average number of strong urge episodes, etc.) Micturition diary	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026